These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1726208)

  • 41. [RU 51807 (cefpodoxime proxetil). In vitro and in vivo antibacterial activity of a new orally administered active cephalosporin].
    Chantot JF; Mauvais P
    Pathol Biol (Paris); 1991 Jan; 39(1):17-27. PubMed ID: 1901403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical evaluation of cefpodoxime in respiratory tract infections].
    Fukuhara H; Irabu Y; Kakazu T; Nakamura H; Shigeno Y; Saito A; Owan T; Oshiro H; Miyaguni T; Nakasone K
    Jpn J Antibiot; 1993 Jan; 46(1):53-9. PubMed ID: 8455331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil.
    Hendrickson JR; North DS
    Ann Pharmacother; 1995 Jun; 29(6):561-5. PubMed ID: 7663025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil.
    Gehanno P; Andrews JM; Ichou F; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():47-51. PubMed ID: 2292530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefpodoxime proxetil: a new, broad-spectrum, oral cephalosporin.
    Chocas EC; Paap CM; Godley PJ
    Ann Pharmacother; 1993 Nov; 27(11):1369-77. PubMed ID: 8286813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.
    Borin MT; Hughes GS; Patel RK; Royer ME; Cathcart KS
    J Clin Pharmacol; 1991 Dec; 31(12):1137-45. PubMed ID: 1761737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orally administered cefpodoxime proxetil for treatment of uncomplicated gonococcal urethritis in males: a dose-response study.
    Novak E; Paxton LM; Tubbs HJ; Turner LF; Keck CW; Yatsu J
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1764-5. PubMed ID: 1416861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefpodoxime proxetil for infective exacerbations of chronic obstructive airway disease.
    Alderman CP
    Ann Pharmacother; 1996 Feb; 30(2):196. PubMed ID: 8835062
    [No Abstract]   [Full Text] [Related]  

  • 49. Multiple dose pharmacokinetics of cefpodoxime in young adult and elderly patients.
    Backhouse C; Wade A; Williamson P; Tremblay D; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():29-34. PubMed ID: 2292527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefpodoxime: pharmacokinetics and therapeutic uses.
    Chugh K; Agrawal S
    Indian J Pediatr; 2003 Mar; 70(3):227-31. PubMed ID: 12785294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical studies of cefpodoxime proxetil in respiratory tract infections].
    Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Takahashi H; Numata H; Takahashi K; Yamaki I; Ishii S
    Jpn J Antibiot; 1988 Oct; 41(10):1538-44. PubMed ID: 3204658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
    Pelc A; Portier H; Gehanno P; Fiessinger S; Ichou F
    Pharmacoeconomics; 1996 Sep; 10(3):239-50. PubMed ID: 10172792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.
    Tremblay D; Dupront A; Ho C; Coussediere D; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():21-8. PubMed ID: 2292526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pharmacoeconomic comparison of amoxicillin/clavulanate and cefpodoxime proxetil in the treatment of acute otitis media.
    Landholt TF; Kotschwar TR
    Clin Ther; 1994; 16(2):327-33; discussion 271-2. PubMed ID: 8062326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetil.
    Dumont R; Guetat F; Andrews JM; Sultan E; Lenfant B
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():41-6. PubMed ID: 2292529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of cefpodoxime proxetil in healthy young and elderly volunteers.
    Borin MT; Ferry JJ; Forbes KK; Hughes GS
    J Clin Pharmacol; 1994 Jul; 34(7):774-81. PubMed ID: 7929873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drugs recently released in Belgium. Cefpodoxime proxetil--Fosinopril.
    Harvengt C
    Acta Clin Belg; 1993; 48(4):284-7. PubMed ID: 8212980
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical evaluation of a new oral cephem, cefpodoxime proxetil in children].
    Meguro H; Arimasu O; Shiraishi H; Tajima T; Hiruma F; Nishimura S; Sugie N; Sugamata K; Abe T; Fujii R
    Jpn J Antibiot; 1989 Jul; 42(7):1561-70. PubMed ID: 2810730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil.
    Borin MT; Hughes GS; Spillers CR; Patel RK
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1094-9. PubMed ID: 2393268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.